Ubs Group Ag Silo Pharma, Inc. Call Options Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SILO
# of Institutions
11Shares Held
120KCall Options Held
0Put Options Held
0-
Virtu Financial LLC New York, NY41.8KShares$46,0320.0% of portfolio
-
Financial Advocates Investment Management Olympia, WA23.9KShares$26,3310.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.3KShares$17,9670.0% of portfolio
-
Geode Capital Management, LLC Boston, MA16.2KShares$17,7960.0% of portfolio
-
State Street Corp Boston, MA12.5KShares$13,7500.0% of portfolio
About Silo Pharma, Inc.
- Ticker SILO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,137,910
- Market Cap $3.45M
- Description
- Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University ...